![G. Todd Milne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
G.
Todd Milne is the founder of Ironwood Pharmaceuticals, Inc., which was founded in 1998.
He held the title of Vice President-Biology from 2009 to 2011.
Dr. Milne also worked as a Principal at the Whitehead Institute for Biomedical Research.
Additionally, he served as the Senior Vice President-External Innovation at Cyclerion Therapeutics, Inc. from 2022 to 2023.
Dr. Milne obtained a doctorate degree from Harvard University and an undergraduate degree from Yale University.
| Unternehmen | Position | Ende |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Corporate Officer/Principal | 01.07.2023 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Corporate Officer/Principal | - |
| IRONWOOD PHARMACEUTICALS, INC. | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
